Literature DB >> 17117226

Hypoglycaemic and hypotensive effects of Momordica charantia Linn (Cucurbitaceae) whole-plant aqueous extract in rats.

John A O Ojewole1, Stephen O Adewole, Gbola Olayiwola.   

Abstract

Various morphological parts (roots, stems, leaves and fruits) of Momordica charantia Linn (family: Cucurbitaceae) are used traditionally in African folk medicine to manage, control and/or treat a plethora of human ailments, including diabetes mellitus and hypertension. In order to scientifically appraise some of the folkloric, anecdotal and ethnomedical uses of M charantia, the present study was undertaken to investigate the hypoglycaemic and hypotensive effects of M charantia whole-plant aqueous extract (MCE) in rat experimental paradigms. The hypoglycaemic effect of the plant extract was examined in normal and diabetic rats, using streptozotocin (STZ)- induced diabetes mellitus models. Normotensive (normal), and hypertensive Dahl salt-sensitive rats were used to probe the hypotensive (antihypertensive) effect of the plant extract. Chlorpropamide was used as reference hypoglycaemic agent for comparison. Acute oral administrations of the plant extract caused dose-related, significant hypoglycaemia in normal (normoglycaemic) and STZ-treated, diabetic rats. Furthermore, acute intravenous administrations of MCE produced dose-dependent, significant reductions in systemic arterial blood pressure and heart rates of normal, and hypertensive Dahl salt-sensitive rats. Although the exact hypoglycaemic and hypotensive mechanisms of action of the plant extract remain speculative at the moment, it is unlikely that the herb causes hypotension in the mammalian experimental animal model used via cholinergic mechanisms, since its cardiovascular effects are resistant to atropine pretreatment. However, the findings of this experimental animal study indicate that the plant extract possesses hypoglycaemic and hypotensive properties, and therefore, lend pharmacological credence to folkloric, ethnomedical uses of the plant in the management and/or control of diabetes mellitus and hypertension in some rural African communities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17117226

Source DB:  PubMed          Journal:  Cardiovasc J S Afr


  17 in total

Review 1.  Bitter melon: a panacea for inflammation and cancer.

Authors:  Prasad R Dandawate; Dharmalingam Subramaniam; Subhash B Padhye; Shrikant Anant
Journal:  Chin J Nat Med       Date:  2016-02

Review 2.  Cardiovascular disease risk reduction in diabetes through conventional and natural approaches.

Authors:  William M Schultz; Elliot N Mahlof; Devinder S Dhindsa; Tina Varghese; Robert E Heinl; Hannah C Cai; Pratik B Sandesara; Danny J Eapen; Laurence S Sperling
Journal:  Cardiovasc Endocrinol       Date:  2017-11-15

Review 3.  Novel nutraceutic therapies for the treatment of metabolic syndrome.

Authors:  Esperanza Martínez-Abundis; Miriam Méndez-Del Villar; Karina G Pérez-Rubio; Laura Y Zuñiga; Marisol Cortez-Navarrete; Alejandra Ramírez-Rodriguez; Manuel González-Ortiz
Journal:  World J Diabetes       Date:  2016-04-10

4.  Double-blind, placebo-controlled clinical evaluation of an Ayurvedic formulation (GlucoCare capsules) in non-insulin dependent diabetes mellitus.

Authors:  R K Sharma; Pralhad S Patki
Journal:  J Ayurveda Integr Med       Date:  2010-01

5.  Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.

Authors:  Rooh Ullah Khan; Mohammad Bashir
Journal:  Nutr J       Date:  2015-01-26       Impact factor: 3.271

Review 6.  Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome.

Authors:  Md Ashraful Alam; Riaz Uddin; Nusrat Subhan; Md Mahbubur Rahman; Preeti Jain; Hasan Mahmud Reza
Journal:  J Lipids       Date:  2015-01-12

7.  Anti-hyperglycaemic globulins from selected Cucurbitaceae seeds used as antidiabetic medicinal plants in Africa.

Authors:  Clautilde Mofor Teugwa; Thaddée Boudjeko; Bruno Tugnoua Tchinda; Pascaline Chouadeu Mejiato; Denis Zofou
Journal:  BMC Complement Altern Med       Date:  2013-03-18       Impact factor: 3.659

8.  Effect of Momordica charantia fruit extract on vascular complication in type 1 diabetic rats.

Authors:  Razif Abas; Faizah Othman; Zar Chi Thent
Journal:  EXCLI J       Date:  2015-01-30       Impact factor: 4.068

9.  Umbelliferone β-D-galactopyranoside from Aegle marmelos (L.) corr. an ethnomedicinal plant with antidiabetic, antihyperlipidemic and antioxidative activity.

Authors:  Vikas Kumar; Danish Ahmed; Amita Verma; Firoz Anwar; Mohammed Ali; Mohd Mujeeb
Journal:  BMC Complement Altern Med       Date:  2013-10-20       Impact factor: 3.659

Review 10.  The therapeutic potential of medicinal foods.

Authors:  Nelvana Ramalingum; M Fawzi Mahomoodally
Journal:  Adv Pharmacol Sci       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.